Evidence map›Paper›PMID 26372699›Full record

ArticleBritish journal of cancer2015

Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy.

Giuseppe Cardillo, Sahar Mokhles, Norman Williams, Fergus Macbeth, Christopher Russell, Tom Treasure

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Giuseppe CardilloCarlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
Sahar MokhlesErasmus University Medical Center, Postbus 2040 3000 CA, Rotterdam, The Netherlands.
Norman WilliamsClinical Trials Group, Division of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, Room 4.24, 132 Hampstead Road, London NW1 2BX, UK.
Fergus MacbethWales Cancer Trials Unit, 6th Floor, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff CF14 4YS, UK.
Christopher RussellDivision of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, Room 4.24, 132 Hampstead Road, London NW1 2BX, UK.
Tom TreasureClinical Operational Research Unit, University College London, 4 Taviton Street, London WC1H 0BT, UK.

Funding

Cancer Research UK 11393Cancer Research UK 19399
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MetastasectomyMutationAdenocarcinomaBiomarkers, TumorColorectal NeoplasmsFemaleHumansLung NeoplasmsMaleProto-Oncogene ProteinsProto-Oncogene Proteins B-rafras ProteinsBiomarkers, TumorProto-Oncogene ProteinsProto-Oncogene Proteins B-rafras Proteins

Identifiers

PMID26372699
PMCPMC4705879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.